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  pidermolysis bullosa (EB) consists of a group of genetic hereditary disorders in which patients frequently present fragile
skin and mucosa that form blisters following minor trauma. More than 20 subtypes of EB have been recognized in the literature.
Specific genetic mutations are well characterized for most the different EB subtypes and variants. The most common oral
manifestations of EB are painful blisters affecting all the oral surfaces. Dental treatment for patients with EB consists of
palliative therapy for its oral manifestations along with typical restorative and periodontal procedures. The aim of this article
is to describe two dental clinical treatments of recessive dystrophic EB cases and their specific clinical manifestations. The
psychological intervention required during the dental treatment of these patients is also presented.
Uniterms: Epidermolysis bullosa. Oral manifestations. Dental caries.
INTRODUCTION
Epidermolysis bullosa (EB) comprises a group of
genetically determined skin fragility disorders characterized
by blistering of the skin and mucosa following mild
mechanical trauma18,20,21. Approximately 400,000-500,000
people are affected worldwide and no definitive treatments
have yet been developed8,7. EB is classified into distinct
subtypes depending on the location of blistering within the
cutaneous dermal-epidermal basement membrane zone. Ten
genes are known to harbor mutations in the major types of
EB, and the level of expression of these genes within the
cutaneous basement membrane zone and in extracutaneous
tissues, as well as the types and combinations of the
mutations, explain, in general terms, the phenotypic
variability22.
The dystrophic forms of EB are characterized by
deformities of the skin including coalescence of the fingers,
blistering, scarring, nail changes and milia formation, and
have either autosomal recessive or dominant inheritance16,20.
In the most severe cases, scars may cause either
ankyloglossia or microglossia3,18.
The major dental complication of EB in general is the
increased risk of caries3. Wright et al.24 have shown that the
prevalence of caries, scored as DMFS (decayed, missing,
filled surfaces), was significantly higher in the junctional
(mean 58.6) and recessive dystrophic (mean 37.6) EB types
than in controls (mean 23.2). It has been hypothesized that
excessive caries is a result of the presence and severity of
the soft tissue involvement, which leads to alteration in diet
(soft and frequently carbohydrate food); increased oral
clearance time (secondary to limited tongue mobility and
vestibular constriction); creation of an abnormal tooth/soft
tissue relationship (i.e., buccal and lingual mucosa, which is
firmly positioned against the tooth); and prevents normal
oral hygiene measures3,10.
Dental treatment is aimed at avoiding the formation of
new bullae during perioperative management, and the choice
of anesthetic method is one of the main issues for dentists
and anesthesiologists21. Special dental concerns involve
the use of soft toothbrushes and irrigation techniques. Purée
diets are recommended because of the lesions involving
the oral mucosa and esophagus. There is also a need for
diet supplements, such as vitamins, proteins and iron in
order to avoid anemia. The use of corticoids, vitamin E and
immunosuppressive drugs have also been suggested for
the treatment of EB1,2,14,19.
The aim of this case report is to describe the oral health
condition of two patients with recessive dystrophic EB and
the treatments provided.
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CASE REPORT
Case 1
A 16-year-old Caucasian girl with recessive dystrophic
EB presented to our dental school for routine treatment.
According to the clinical interview, hemorrhagic blisters in
the mouth had been detected since early infancy. With the
patient’s growing and physical development, lesions
extended to the face, feet and hands. Due to her great
difficulty in performing adequate oral hygiene, almost all of
her teeth had been destroyed by caries lesions and were
covered with dental plaque (Figure 1A and B). Her oldest
sister had died one year before as a consequence of the
same disease.
The patient’s mental status was appropriate for her age.
However, her physical development was delayed and her
weight and height were compatible with that expected for a
9 year-old child. During physical examination, several blisters
were observed in several areas of the body, and they quickly
appeared right after mild pressure on her lips. Her fingernails
and toenails were absent and her hands showed some degree
of deformity. Her tongue presented no papillae. She also
presented ankyloglossia and microstomia, probably due to
secondary scars from repeated episodes of blistering and
subsequent healing.
After evaluation of the panoramic radiograph (Figure 2)
and intraoral examination, a treatment plan was established.
Extraction of maxillary right first molar, first premolar, lateral
incisor and central incisor, maxillary left central incisor, lateral
incisor and first premolar, mandibular left first molar,
mandibular right first and second premolars and first molar,
and restorative treatment of second premolar, canine,
mandibular left first premolar and mandibular right lateral
incisor were recommended. At beginning of the dental
treatment the patient was poorly cooperative and did not
permit even a simple dental examination. The option for
dental extraction as part of the treatment plan was based on
the clinical limitations associated with the patient’s disease.
Microstomia, blister formation and the poor patient
cooperation all together made the surgical procedures even
more difficult and challenging. Dental plaque was disclosed
and the patient was taught how to improve her oral hygiene
through better brushing techniques and the additional use
of a 0.12% chlorhexidine solution applied topically with a
FIGURE 1- A= Frontal view of open mouth with patient’s help. The limitation of mouth opening was a consequence of
microstomia. B = Maximal upper occlusal view
A B
FIGURE 2- Panoramic radiograph showing the oral health status
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cotton bud after lunch and at bed time for 7 days.
Following the patient’s conditioning therapy, the
surgical procedures were carried out in 5 weekly
appointments (Figure 3A). At all extraction sections, first a
topical local anesthetic was applied for 4 minutes. Right
after, one cartridge (1.8 mL) of local anesthetic solution, 2%
mepivacaine with 1:100,000 adrenaline, was infiltrated.
During the application of the local anesthetic solution, blister
formation occurred. To avoid trauma to the fragile oral
mucosa, precautions were adopted, including the use of
gentle pressure during the surgeries and no suture usage.
After each extraction, the healing process was very rapid
and the patient did not complain about any pain (Figure
3B).
A prosthetic appliance with two central incisors was
prepared to replace the four maxillary anterior teeth, and it
was delivered after the maxillary extractions had been
completed (Figure 4). The delay for delivering the appliance
was purposeful, in order to give the patient motivation to
cooperate with the required surgical and restorative
procedures. The restorative treatment using glass ionomer
cement was accomplished within 5 weeks.
The patient was followed for 3 years for control of the
prosthetic appliance and oral health.
FIGURE 3- A= Immediate (maxillary right central and lateral incisors) and 7-day (maxillary left central and lateral incisors)
postoperative aspect. Note the hemorrhagic blisters on the lip and palate after surgery. B= Oral aspect 1 month after the first
surgical procedure
A B
FIGURE 4- Frontal view of the patient’s face partially showing
the prosthetic appliance with two upper incisors
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Case #2
A 5-year-old African-American boy was admitted to
treatment, because of white spot lesions, at our institution.
The patient had had recessive dystrophic EB since birth.
There was no family history of EB. His mother’s pregnancy
had been full term and uncomplicated. He presented
ulceration, lesions and blister formation on the hands, feet,
knees, trunk, elbows, face, scalp, lips and inside the mouth.
The fingers of both hands had become fused.
Intraorally, blisters of various sizes were seen on the
tongue, gingiva and oral mucosa. The gingival tissue was
red, edematous and ulcerated. The mucous membrane was
extremely friable, easily yielding sloughs when touched. The
teeth had advanced white spot lesions, and there was
deposition of dental plaque on all teeth (Figure 5). The patient
reported feeding difficulties only when the blisters were
very painful.
After the contact with the patient’s physician, a
panoramic radiograph was taken and a treatment plan was
developed (Figure 6). Dental plaque and white spot lesions
control was weekly recommended. Thus, conditioning
sessions were adopted in order to obtain the patient’s trust.
Dental plaque was controlled with professional prophylaxis
and use of 0.12% chlorhexidine gel applied topically.
Fluoridated varnish was applied on white spot lesions.
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The patient has been under control of oral health since
he was 2 years old. He uses a 0.05% fluoridated solution
applied topically with a cotton bud on all teeth once daily.
At the moment, the patient is 5 years old.
DISCUSSION
Physiopathologically, EB is caused by anomalous
adhesion of the epithelial components. This occurs at
different levels, depending on the subtype of EB. In the
junctional and dystrophic forms, the separation occurs
through the lucent lamina of the basement membrane and
the lamina densa, respectively. Due to the lack of cohesion,
blisters form following minor trauma. In both cases presented
in this work, blisters formed after mild pressure on the
mouth15,16 and during administration of local anesthetic
solution11 (Case 1). Although the clinical manifestations
suggested EB diagnosis in both cases presented hereby,
confirmation was granted by histopathologic study
conducted at Lauro de Souza Lima Hospital, Bauru, SP,
Brazil.
In some subtypes of EB, the oral cavity is susceptible to
injury. Erosions, blisters and eventually a tongue without
papillae are observed in addition to ankyloglossia and
microstomia2,12,17,23,24. In our cases, the presence of
polymorphic lesions involving the oral mucous membrane
and tongue were present. The loss of tongue papillae and
ankyloglossia could be related both to the long duration of
the disease in these patients and to the fact that they suffer
from the most severe form of epidermolysis10,13.
The treatment for patients with EB is multidisciplinary
and, unfortunately, no specific therapeutic regimen can cure
the disease7,8. Secondary infections must be treated with
topical and/or systemic antibiotics and a protein-rich diet,
iron and zinc must be provided11,14,16,19. While systemic
treatment remains primarily palliative, it is possible to prevent
destruction and subsequent loss of the dentition by means
of appropriate interventions and dental therapy7,16.
The dental treatment of the patient of Case 1 was not
very simple, whereas the patient of Case 2 required only
preventive measures. In Case 1, the patient’s physical and
FIGURE 6- Panoramic radiograph showing the oral health status
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FIGURE 5- Frontal view of open mouth. The limitation of
mouth opening was a consequence of the microstomia
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psychological suffering resulted in very reluctant behavior
and in a special ability to involve her parents. Parents’
indulgence, a common characteristic in cases like this in
which an actual life-threatening condition is present, has
contributed significantly to her poor oral status4,8,15.
Treatment modalities that help decreasing patient’s
anxiety are advisable. They provide safer treatment and help
reducing the consequent effects of trauma to the soft tissues
from dental treatment. This could also diminish the number
of exposures. Although moderate sedation was not used
for treating the patient of Case 1, it is a good option for
management of oral condition of anxious patients5,6 because
it allows for completion of a larger number of procedures in
single session, thus reducing the number of visits, repeated
oral trauma and bullous formation. Hence, the amount of
resulting scarring and constrictures, especially in a very
apprehensive patient with acute dental anxiety, is reduced5.
Moreover, regular dental evaluation and treatment is
imperative and should be instituted as early as possible9,15,
similarly to what has been done for the patient of Case 2.
CONCLUSION
Dentists should be aware of the presentation of EB to
assist in early diagnosis and to provide the patient with the
proper preventive and/or restorative treatment. The present
cases emphasize the importance for recognition of EB and
the need for multidisciplinary treatment of affected patients.
Due to the great difficulty and risk of providing dental
treatment to patients with EB, prevention of caries and
periodontal disease must be emphasized at a very young
age.
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